Recombinant Domain of Flagellin Promotes In Vitro a Chemotactic Inflammatory Profile in Human Immune Cells Independently of a Dendritic Cell Phenotype
Molecules · 2023
DOI: 10.3390/molecules28052394 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Roxana González-Stegmaier und 4 weiteren Autor:innen. Beteiligte Einrichtung: Translational Medicine Laboratory, Instituto Oncológico Fundación Arturo López Pérez, Santiago 8320000, Chile. Hauptthemen laut MEDLINE: Flagellin, Chemotaxis, Leukocyte. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: FONDECYT, Instituto Oncológico Fundación Arturo López Pérez, National Fund for Scientific and Technological Development, FONDECYT.
Abstract (Originalsprache)
Flagellin is the major component of the flagellum in gram-positive and -negative bacteria and is also the ligand for the Toll-like receptor 5 (TLR5). The activation of TLR5 promotes the expression of proinflammatory cytokines and chemokines and the subsequent activation of T cells. This study evaluated a recombinant domain from the amino-terminus D1 domain (rND1) of flagellin from Vibrio anguillarum, a fish pathogen, as an immunomodulator in human peripheral blood mononuclear cells (PBMCs) and monocyte-derived dendritic cells (MoDCs). We demonstrated that rND1 induced an upregulation of proinflammatory cytokines in PBMCs, characterized at the transcriptional level by an expression peak of 220-fold for IL-1β, 20-fold for IL-8, and 65-fold for TNF-α. In addition, at the protein level, 29 cytokines and chemokines were evaluated in the supernatant and were correlated with a chemotactic signature. MoDCs treated with rND1 showed low levels of co-stimulatory and HLA-DR molecules and kept an immature phenotype with a decreased phagocytosis of dextran. We probed that rND1 from a non-human pathogen promotes modulation in human cells, and it may be considered for further studies in adjuvant therapies based on pathogen-associated patterns (PAMPs).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Translational Medicine Laboratory, Instituto Oncológico Fundación Arturo López Pérez, Santiago 8320000, Chile.
- Laboratorio de Microbiología Molecular, Escuela de Tecnología Médica, Universidad Austral de Chile, Puerto Montt 5480000, Chile.
ORCID-Profile: Roxana González-Stegmaier, Patricia Aguila-Torres, Franz Villarroel-Espíndola
Förderung
- FONDECYT
- Instituto Oncológico Fundación Arturo López Pérez
- National Fund for Scientific and Technological Development, FONDECYT
Zitieren
APA
González-Stegmaier, R., Aguirre, A., Cárcamo, C., Aguila-Torres, P., & Villarroel-Espíndola, F. (2023). Recombinant Domain of Flagellin Promotes In Vitro a Chemotactic Inflammatory Profile in Human Immune Cells Independently of a Dendritic Cell Phenotype. Molecules. https://doi.org/10.3390/molecules28052394
Vancouver
González-Stegmaier R, Aguirre A, Cárcamo C, Aguila-Torres P, Villarroel-Espíndola F. Recombinant Domain of Flagellin Promotes In Vitro a Chemotactic Inflammatory Profile in Human Immune Cells Independently of a Dendritic Cell Phenotype. Molecules. 2023. doi:10.3390/molecules28052394
BibTeX
@article{GonzlezStegmaier2023,
author = {González-Stegmaier, Roxana and Aguirre, Adam and Cárcamo, Constanza and Aguila-Torres, Patricia and Villarroel-Espíndola, Franz},
title = {Recombinant Domain of Flagellin Promotes In Vitro a Chemotactic Inflammatory Profile in Human Immune Cells Independently of a Dendritic Cell Phenotype},
journal = {Molecules},
year = {2023},
doi = {10.3390/molecules28052394}
}
EUVIMED